Santiago v. Sherwin-Williams Co.

Decision Date02 July 1992
Docket NumberCA No. 87-2799-T.
Citation794 F. Supp. 29
PartiesMonica SANTIAGO, Plaintiff, v. SHERWIN-WILLIAMS COMPANY, et al., Defendants.
CourtU.S. District Court — District of Massachusetts

Jonathan Shapiro, Stern & Shapiro, Neil T. Leifer, Stephen J. Kiely, Thornton & Early, Boston, Mass., Judith E. Somberg, Johnson & Somberg, Jamaica Plain, Mass., Arthur Bryant, Washington, D.C., for plaintiffs.

Thomas V. Urmy, Jr., Shapiro, Grace & Haber, Mary Morrissey Sullivan, Sullivan, Sullivan & Pinta, Lawrence Gerard Cetrulo, Burns & Levinson, Peter S. Terris, Palmer & Dodge, Thomas J. Griffin, Jr., Goodwin, Proctor & Hoar, Rory John Fitzpatrick, Rory Fitzpatrick, Meghan H. Magruder, John C. Solomon, Bingham, Dana & Gould, Boston, Mass., Janie S. Mayeron, G. Marc Whitehead, Ellen Maas, Michael L. Nilan, Popham, Haik, Schnobrich & Kaufman, Ltd., Minneapolis, Minn., Kirsten K. Robbins, Kirkland & Ellis, Washington, D.C., Paul Michael Pohl, Charles H. Moellenberg, Jones, Day, Reavis & Pogue, for defendants.

MEMORANDUM

TAURO, Chief Judge.

Plaintiff Monica Santiago brought this tort action against several defendants1 alleging that their manufacture of lead pigment for use in lead paint caused her injury. In an earlier opinion, this court refused to apply market share liability theory in the context of lead paint poisoning. Santiago v. Sherwin-Williams Co., 782 F.Supp. 186 (D.Mass.1992) (Santiago I). Presently at issue is whether plaintiff may pursue her claims under either a concert of action or an enterprise liability theory.

The gravamen of plaintiff's claim is that defendants implicitly agreed to produce, market and promote lead pigment, and to refrain from warning of known health risks associated with the product. The parties' motions for summary judgment are before the court.

I. Concert of Action

Massachusetts law recognizes the concert of action theory of tort liability.2 Under this theory, a defendant who has an agreement with another to perform a tortious act or to achieve a tortious result, may be liable to a plaintiff, even if that defendant was not the cause-in-fact of the injury. Payton, 512 F.Supp. at 1035 (citing Gurney v. Tenney, 197 Mass. 457, 466, 84 N.E. 428 (1908)). Plaintiff need not prove the existence of an agreement by direct evidence. See Nelson v. Nason, 343 Mass. 220, 222, 177 N.E.2d 887 (1961) (drag racing). Rather, an agreement may be inferred if the conduct of the defendants suggests a tortious implied meeting of the minds. Payton, 512 F.Supp. at 1035; Nelson, 343 Mass. at 222, 177 N.E.2d 887.

Defendants argue that, since plaintiff cannot identify any one defendant as the cause of her harm, they are entitled to judgment as a matter of law. See Celotex Corp. v. Catrett, 477 U.S. 317, 322-23, 106 S.Ct. 2548, 2552-53, 91 L.Ed.2d 265 (1986) (failure of proof on an essential element of plaintiff's claim mandates summary judgment). Plaintiff responds that Massachusetts' version of concert of action relaxes the identification requirement.

A.

The classic paradigm of concerted action is a drag race where one driver is the cause-in-fact of plaintiff's injury and the fellow racer is also held liable for the injury. See, e.g., Marshall v. Celotex Corp., 691 F.Supp. 1045, 1047 (E.D.Mich.1988).3 Courts typically apply the theory when "a particular defendant is already identified as causing the plaintiff's harm, and the plaintiff desires to extend liability to those acting in league with that defendant." Sabean v. Marshall's Inc., No. 55978, slip op. at 14 (Suffolk Super.Ct. May 20, 1985) (citing Collins v. Eli Lilly Co., 116 Wis.2d 166, 342 N.W.2d 37, 47, cert. denied, 469 U.S. 826, 105 S.Ct. 107, 83 L.Ed.2d 51 (1984)); see also Zafft, 676 S.W.2d at 245 (concerted action "developed, not to relieve plaintiffs of the burden of identifying the wrongdoer, but to impose liability on culpable co-participants").

Massachusetts courts have recognized concert of action liability only under the narrow circumstances of a drag race. See Orszulak v. Bujnevicie, 355 Mass. 157, 243 N.E.2d 897 (1969); Nelson v. Nason, 343 Mass. 220, 177 N.E.2d 887 (1961). Other courts have generally held that the concert of action theory is inapplicable when the plaintiff cannot identify at least one defendant as the cause-in-fact of injury. In other words, under concert of action "the requirement of causation remains intact." Morton v. Abbott Laboratories, 538 F.Supp. 593, 595 (M.D.Fla.1982); see also Marshall, 691 F.Supp. at 1047 (concert of action theory not fashioned to ease plaintiff's burden of proving causation); Collins, 342 N.W.2d at 47 (concert of action theory "rarely has been used to help plaintiffs avoid the identification requirement"); Burnside v. Abbott Laboratories, 351 Pa.Super. 264, 505 A.2d 973, 984 (1985) (DES plaintiff could not maintain concert of action claim where she is "unable to isolate a particular manufacturer as a causative agent of her injuries"); Smith v. Eli Lilly & Co., 173 Ill.App.3d 1, 122 Ill.Dec. 835, 852, 527 N.E.2d 333, 350 (1988) ("concerted action is normally applied to situations where, unlike this DES case, a specific defendant is already identified as causing the plaintiff's harm, and the plaintiff wishes to extend liability to others acting with that defendant"), rev'd on other grounds, 137 Ill.2d 222, 148 Ill.Dec. 22, 560 N.E.2d 324 (1990).4

B.

There is some authority for accepting a less stringent standard with respect to application of the concert of action theory. See Kathy J. Owen and C. Vernon Hartline, Jr., Industry-wide Liability: Protecting Plaintiffs and Defendants, 44 Baylor L.Rev. 45, 52 (Winter 1992) (courts have extended concert of action theory "to adapt to the difficulties of identification problems confronted in the rapidly developing area of strict products liability").5 In Abel v. Eli Lilly and Co., 418 Mich. 311, 343 N.W.2d 164, 176 (1984), for example, the court allowed a DES plaintiff to proceed under concert of action, even though she could not identify the defendant that was the cause-in-fact of her injury. Other courts have indicated that concert of action may operate to bypass the traditional identification requirement. See, e.g., Hymowitz, 541 N.Y.S.2d at 945, 539 N.E.2d at 1073 ("The accepted tort doctrines of alternative liability and concert of action are available in some personal injury cases to permit recovery where the precise identification of a wrongdoer is impossible."); Farmer v. Newport, 748 S.W.2d 162, 164 (Ky.App.1988) ("Since the nature of the concert of action theory is one of joint control and risk, the plaintiff need not identify the specific defendant who caused the injury.").

These cases, however, are distinguishable. Abel and Hymowitz both involved DES plaintiffs, who could demonstrate a signature injury. See Santiago I, 782 F.Supp. at 193 (refusing to apply market share theory—and, therefore, to relax the identification requirement—because of the "possibility that the defendants did not cause the harm in question"). In Farmer, the plaintiffs sued manufacturers for negligence in making mattresses that were combustible. There, however, the plaintiffs were able to identify one of the mattress manufacturers. 748 S.W.2d at 164.

The Massachusetts Supreme Judicial Court has indicated that it would relax the identification requirement only in circumstances that would limit a defendant's liability to the harm it actually caused. Payton v. Abbott Labs, 386 Mass. 540, 437 N.E.2d 171, 188 (1982). See also Santiago I, 782 F.Supp. at 191-92 (discussing the identification requirement under Massachusetts law). Under concert of action theory, however, liability is joint and several. See, e.g., Marshall, 691 F.Supp. at 1048; Rastelli v. Goodyear Tire & Rubber Co., 79 N.Y.2d 289, 582 N.Y.S.2d 373, 375, 591 N.E.2d 222, 224 (1992); Smith v. Cutter Biological, Inc., 72 Haw. 416, 823 P.2d 717, 726 (1991). If applied here, therefore, a lead pigment manufacturer could be held liable for 100 percent of plaintiff's injury, even if it did not actually cause her injury. Under plaintiff's proposed application, "the concert of action theory contains no limitations to defendants' liability. Defendants may not show that another is the cause in fact of the injury and absolve themselves of liability." Marshall, 691 F.Supp. at 1048; see also Smith, 823 P.2d at 726 (unfair to hold blood product manufacturers jointly and severally liable under concert of action theory). Applying concert of action here would "expand the doctrine far beyond its intended scope." Sindell v. Abbott Laboratories, 26 Cal.3d 588, 163 Cal. Rptr. 132, 141, 607 P.2d 924, 933, cert. denied, 449 U.S. 912, 101 S.Ct. 285, 66 L.Ed.2d 140 (1980).

This court concludes, therefore, that in the absence of an identifiable tortfeasor, plaintiff may not pursue her concert of action claim.

II. Enterprise Liability

Enterprise liability is a variation of concert of action.6 Its application to lead pigment manufacturers is a matter of first impression. Under this theory, an entire industry may be held liable for its collective wrongdoing. See Hall v. E.I. Du Pont de Nemours & Co., 345 F.Supp. 353 (E.D.N.Y. 1972) (manufacturers of blasting caps that injured children could be held liable for omitting a warning and failing to take safety measures). In Hall, the court explained the application of enterprise liability:

Plaintiffs ... will have to demonstrate defendants' joint awareness of the risks at issue in this case and their joint capacity to reduce or affect those risks. By noting these requirements we wish to emphasize their special applicability to industries composed of a small number of units. What would be fair and feasible with regard to an industry of five or ten producers might be manifestly unreasonable if applied to a decentralized industry composed of thousands of small producers.

Id. at 378.7 See also Vigiolto v. Johns-Manville Corp., 643 F.Supp. 1454, 1457 (W.D.Pa.1986) ("Enterprise liability exists...

To continue reading

Request your trial
7 cases
  • In re Methyl Tertiary Butyl Ether ("Mtbe") Prod.
    • United States
    • U.S. District Court — Southern District of New York
    • 20 August 2001
    ...is inapplicable when the plaintiff cannot identify which defendant is the cause-in-fact of injury, see, e.g., Santiago v. Sherwin-Williams Co., 794 F.Supp. 29, 32-33 (D.Mass.1992) (rejecting application of concert of action liability to Massachusetts lead-based paint case); Marshall, 691 F.......
  • Dow Chemical Co. v. Mahlum
    • United States
    • Nevada Supreme Court
    • 31 December 1998
    ...one driver is the cause-in-fact of plaintiff's injury and the fellow racer is also held liable for the injury. Santiago v. Sherwin-Williams Co., 794 F.Supp. 29, 31 (D.Mass.1992), aff'd, 3 F.3d 546 (1st Cir.1993). Similarly, one court remarked that application of the doctrine of concert of a......
  • Fakoya v. Cnty. of Clark
    • United States
    • U.S. District Court — District of Nevada
    • 8 October 2014
    ...11, 15 (Nev. 2001). 97. Id. (citing Nev. Rev. Stat. § 41.141(5)(d)). 98. Dow Chem., 970 P.2d at 111 (citing Santiago v. Sherwin-Williams Co., 794 F.Supp. 29, 31 (D. Mass.1992)). 99. Id. (quoting Juhl v. Airington, 936 S.W.2d 640, 644 (Tex. 1996)). 100. Dow Chem., 970 P.2d at 111 (quoting Ha......
  • Hurt v. Philadelphia Housing Authority
    • United States
    • U.S. District Court — Eastern District of Pennsylvania
    • 27 August 1992
    ...now been rejected by virtually every other jurisdiction confronted with this issue." Id. at 971 n. 6. See also Santiago v. Sherwin-Williams Co., 794 F.Supp. 29 (D.Mass. 1992) (rejecting application of enterprise liability to Massachusetts lead-based paint case). The court went on to quote w......
  • Request a trial to view additional results
1 books & journal articles

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT